Anaesthesia, critical care & pain medicine · 2026
Perioperative ketamine or esketamine for acute postoperative pain after laparoscopic cholecystectomy: A systematic review and meta-analysis with meta-regression.
Систематический обзорСтатьяМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Akram Umar, Fatima Eeshal, Ashraf Hamza, Abdul Rehman Khawaja, Raza Muhammad Ahmed, Qazi Muhammad Saeed, Ahmad Eeman, Rehman Fasih Khalil Ur, Chaudhary Ahmed Jamal, Ratnani Iqbal, Surani Salim
Аннотация
BACKGROUND: This systematic review and meta-analysis investigated the effectiveness and safety of perioperative ketamine/esketamine in patients undergoing laparoscopic cholecystectomy (LC).
METHODS: A literature search was conducted across Medline, Embase, Google Scholar, and clinicaltrials.gov until April 2025. Forty-eight randomized controlled trials (RCTs) comparing ketamine/esketamine with a control in LC patients and assessing postoperative pain scores were included. Statistical analysis was performed using R.
RESULTS: This review included a total of 48 RCTs (n = 3508). Pooled analysis revealed that intervention significantly reduced postoperative pain at 4 (mean difference [MD]: -1.11, I² = 97.8%, p = 0.044, very low-certainty evidence) and 6 h (MD: -0.40, I² = 86.1%, p = 0.019, very low-certainty evidence), 24-h opioid consumption (MD: -4.10, I² = 98.3%, p = 0.024, very low-certainty evidence) and need for rescue analgesia (risk ratios [RR]: 0.64, I² = 36%, p = 0.006, very low-certainty evidence) compared to the control. According to subgroup analysis on the basis of regimen, esketamine significantly reduced postoperative pain at 1 (MD: -0.67, I² = 0%, p = 0.034) and 2 h (MD: -0.91, I² = 79.3%, p = 0.008). Ketamine significantly reduced 24-h opioid consumption (MD: -5.35, I² = 96%, p = 0.01) and the need for rescue analgesia (RR: 0.64, I² = 41.7%, p = 0.011). Safety analysis revealed the significantly increased risk of hallucinations, diplopia, and nystagmus with the intervention.
CONCLUSION: With a very low level of certainty, this meta-analysis demonstrated that ketamine/esketamine might help reduce acute postoperative pain and postoperative opioid needs in patients undergoing LC. Furthermore, ketamine may slightly increase the risk of some adverse events. However, dose-related meta-regression for adverse events was not performed due to inconsistent reporting across studies.
REGISTRATION: PROSPERO (CRD420251035913).
METHODS: A literature search was conducted across Medline, Embase, Google Scholar, and clinicaltrials.gov until April 2025. Forty-eight randomized controlled trials (RCTs) comparing ketamine/esketamine with a control in LC patients and assessing postoperative pain scores were included. Statistical analysis was performed using R.
RESULTS: This review included a total of 48 RCTs (n = 3508). Pooled analysis revealed that intervention significantly reduced postoperative pain at 4 (mean difference [MD]: -1.11, I² = 97.8%, p = 0.044, very low-certainty evidence) and 6 h (MD: -0.40, I² = 86.1%, p = 0.019, very low-certainty evidence), 24-h opioid consumption (MD: -4.10, I² = 98.3%, p = 0.024, very low-certainty evidence) and need for rescue analgesia (risk ratios [RR]: 0.64, I² = 36%, p = 0.006, very low-certainty evidence) compared to the control. According to subgroup analysis on the basis of regimen, esketamine significantly reduced postoperative pain at 1 (MD: -0.67, I² = 0%, p = 0.034) and 2 h (MD: -0.91, I² = 79.3%, p = 0.008). Ketamine significantly reduced 24-h opioid consumption (MD: -5.35, I² = 96%, p = 0.01) and the need for rescue analgesia (RR: 0.64, I² = 41.7%, p = 0.011). Safety analysis revealed the significantly increased risk of hallucinations, diplopia, and nystagmus with the intervention.
CONCLUSION: With a very low level of certainty, this meta-analysis demonstrated that ketamine/esketamine might help reduce acute postoperative pain and postoperative opioid needs in patients undergoing LC. Furthermore, ketamine may slightly increase the risk of some adverse events. However, dose-related meta-regression for adverse events was not performed due to inconsistent reporting across studies.
REGISTRATION: PROSPERO (CRD420251035913).